Orlaskin Hydrating Sunscreen
Over-the-Counter品牌名称： ORLASKIN HYDRATING SUNSCREEN
About This Medication
Health product used for symptom relief and wellness support.
活性成分
| 成分 | 规格 |
|---|---|
| Avobenzone | - |
| Homosalate | - |
| Octisalate | - |
| Octocrylene | - |
适应证与用法
用法用量
警告与注意事项
Warnings For external use only. Avoid contact with eyes , wear protective clothing , hats and eyewear when exposed to the sun . Avoid prolonged exposure in the sun. Keep out of reach of children. Do not use on damaged or brokenskin. Store in a cool , dry place and avoiddirect sunlight. If using with other sun protection products , consult with a doctor before use.
Frequently Asked Questions
Uses Helps prevent sunburn. If used as directed with other sun protection measures ( see directions ), decreases the risk of skin cancer and early skin ageing caused by the sun.
Directions Shake the spray bottle well before use. Hold the spray bottle at an appropriate distance from the face and neck . Spray evenly onto the entire face and neck area. Avoid direct contact with eves . In case of eye contact , rinse immediately with water. For continued sun protection , reapply every 2 hours
Warnings For external use only. Avoid contact with eyes , wear protective clothing , hats and eyewear when exposed to the sun . Avoid prolonged exposure in the sun. Keep out of reach of children. Do not use on damaged or brokenskin. Store in a cool , dry place and avoiddirect sunlight. If using with other sun protection products , consult with a doctor before use.
Orlaskin Hydrating Sunscreen is available over the counter (OTC) without a prescription.
Similar Other Products
Browse all Other products →References & Data Sources
- • DailyMed — Orlaskin Hydrating Sunscreen drug label (National Library of Medicine)
- • openFDA — Orlaskin Hydrating Sunscreen label data (U.S. Food & Drug Administration)
- • NDC Directory — Orlaskin Hydrating Sunscreen (FDA National Drug Code)
医疗免责声明
本页面信息仅供教育参考之用，不得用于替代专业医疗建议、诊断或治疗。
如有任何关于病症或药物的疑问，请务必咨询您的医生或其他具有资质的医疗保健提供者。
数据来源： DailyMed (NLM), openFDA, MFDS